Clinical Trials Directory

Trials / Completed

CompletedNCT00601042

Serbian Smoking Reduction/Cessation Trial (2SRT)

Randomized, Placebo-controlled, Double-blind, Phase IV Trial to Assess the Efficacy of a Traditional Swedish Smokeless Tobacco Product ("Snus") to Reduce or Replace Cigarette Smoking Among Adult Smokers in Serbia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
319 (actual)
Sponsor
Swedish Match AB · Industry
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Accepted

Summary

The study aims to establish if a low-nitrosamine, smokeless tobacco product (Swedish snus) can help adult smokers to reduce and eventually completely quit smoking.

Conditions

Interventions

TypeNameDescription
OTHERSwedish snus (smokeless tobacco)Snus in sachets 1.0 g or 0.5 g, 2 flavors. Usage ad libitum.
OTHEROnicoTobacco-free, nicotine-free placebo snus, 2 sachet sizes (1.0 g, 0.5 g), 2 flavors (same as in the experimental arm). Usage ad libitum.

Timeline

Start date
2008-01-01
Primary completion
2010-06-01
Completion
2010-06-01
First posted
2008-01-25
Last updated
2013-12-11

Locations

2 sites across 1 country: Serbia

Source: ClinicalTrials.gov record NCT00601042. Inclusion in this directory is not an endorsement.

Serbian Smoking Reduction/Cessation Trial (2SRT) (NCT00601042) · Clinical Trials Directory